Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SIX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Investors

Financial Calendar

Publication of Annual Report 2008: April 2, 2009

Press and Analyst conference: Zurich, April 2, 2009

Annual Shareholders' meeting:  Milan, April 27, 2009

Half year report 2009:  September 10, 2009